Pharmaceutical Bottles Market Intelligence

Are you looking for answers on Pharmaceutical Bottles category?

Are you looking for answers on Pharmaceutical Bottles category?

  • What are the key trends in Pharmaceutical Bottles category?
  • Am I paying the right price?
  • Am I working with the right supplier?
  • What are the major challenges and risks in Pharmaceutical Bottles industry?
  • How is Pharmaceutical Bottles industry performing?

Over 50,000+ users trust Beroe

Report Coverage

  • Key Mergers and Acquisitions
  • Innovations – Pharmaceutical Bottles
  • Growth Drivers and Constraints – Plastic Bottles
  • Cost Break Up of Plastic Bottles and Caps – North America

Production Size

CAGR

0.606 MMT

Production Size Western Europe

0.226 MMT

Production Size Asia Pacific (APAC)

0.762 MMT

Production Size Latin America (LATAM)

0.206 MMT

Table of contents

  1. Executive Summary
  1. Value Chain Analysis - Pharmaceutical Bottles
  1. Pharmaceutical Plastic Bottles - Market Outlook - Global
  1. Pharmaceutical Plastic Bottles - Market Outlook - Regional
  1. Pharmaceutical Bottles - Industry Trends
  1. Pharmaceutical Bottles - Key Innovations
  1. Key Drivers
  1. Cost Outlook and Drivers
  1. Pharmaceutical Bottles Supplier Intelligence

Want a more detailed personalised report?

Global Market Outlook on Pharmaceutical Bottles

The increasing adoption of pharma bottles for unit dose packaging particularly from high demand regions like APAC is expected to acquire more market from other packaging formats like blister, cartons, etc., The global demand for blow molded pharmaceutical bottles was estimated at about 2.06 MMT and is expected to grow at a CAGR of about 5-6 percent between 2017-22, driven by increasing demand for pharma products in emerging regions and preference for plastic over glass bottles.

  • The global pharmaceutical packaging market is forecasted to grow at a CAGR of 5–6 percent between 2017 and 2022. APAC is expected to drive the growth, as a result of ageing population, demanding medication and increased contract manufacturing activities
  • Plastic bottles' contribution in the global pharmaceutical packaging was recorded as the highest, 22 percent by value. Over 80 percent of all pharma bottles were HDPE. Growing bulk purchase preference of tablets especially in the developed countries is likely to sustain bottle volumes
  • Preference of HDPE bottles exceeds the demand of traditional packaging forms like glass bottles, due to its better light weighting and oxygen barrier properties which directly impacts the shelf life of the drug

Pharma plastic bottles market size

North America - Market Outlook for Pharma Plastic Bottles 

  • North America pharma bottle market is expected to witness growth of around 5-6 percent CAGR between 2017-22, majorly driven by the increasing consumer preference for buying bulk doses in OSD segments
  • Plastic bottles are facing strong competition from the blister packaging, which accounts for the second highest market share catering to the unit dose segment which reflects a slight shift in the unit dose preference from the North American market
  • Demand for pre-fillable inhalers is expected to be higher than pharma packaging due to recent innovations that have made such devices popular with asthma patients

Europe - Market Outlook for Pharma Plastic Bottles

Europe has a large number of strong domestic and global suppliers with high innovation capabilities and large product portfolio. This would limit any supply or innovation availability challenges in Europe.The  growing cost saving measures undertaken by the European government to reduce drug development expenditures, would increase the pricing pressures on packaging suppliers in future. This could also drive innovation in cost containment

  • The European pharma bottles market is forecasted to grow at 3-4 percent (CAGR) during 2017–2022, driven by the strong growth in Eastern Europe (~6-7 percent CAGR)
  • Plastic bottles in Europe had the largest market share in primary packaging, with 20 percent market share of the total pharmaceutical primary packaging. This is expected to sustain in the next five years
  • Major growth is expected to from process innovations, like BFS and multi-layering of the HDPE bottles, which improves the bottles barrier properties, resulting in the enhancement of the shelf life of the packed drugs
  • Guidelines on senior friendly and child-resistant packaging have made the plastic bottle manufacturers to incorporate new technologies to serve the growing demand. As these regulations and guidelines are mandatory, there are multiple innovations being developed in this front

Trends – Pharmaceutical Bottles

  • Major demand of Anti Counterfeiting products are coming from developed markets like North America and Europe as proper guidelines have been laid down in these markets and the markets are well-equipped to implement these changes
  • Innovations in track and trace technologies would be the key area of focus and growth in the packaging industry for the next 3-4 years. RFIDs are replacing barcodes as the preferred track and trace method.
  • COC bottles, made of cyclic olefins, are considered to be a potential threat to PET bottles in packaging oral doses and drugs. COC bottles have the required resistance for drugs compared to PET or HDPE, but are 30% costlier than PET bottles
  • Through a double lamination system, the COC bottles can be made cheaper in a way to coat the inner part with COC and outer with HDPE coating
  • BFS or Blow-Fill-Seal is an innovative technology, in which, the blow-mold filling of the drug and then sealing is done in a sequential process
  • This technology will help to reduce additional time and the cost taken for packaging the drug. It reduces the lead time and also improves the overall efficiency of the packaging process

Complimentary 12-month access to Beroe LiVE

Any more questions?

Get in touch with us quickly and easily.